Earnings › Eli Lilly · Eli Lilly company page · insider trades
Eli Lilly earnings
Eli Lilly (LLY) quarterly revenue, net income and diluted EPS from its SEC filings, the upcoming report date, and links to each earnings release. Last update 2026-10-03.
The next report date hasn't been announced by Eli Lilly yet.
Subscribe to Eli Lilly earnings dates in your calendar app (updates automatically)
Quarterly results
| Quarter | Revenue | YoY | Net income | YoY | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 ended Jun 30, 2026 | $22.97B | +48% | $7.09B | +25% | $7.94 |
| Q1 2026 ended Mar 31, 2026 | $19.80B | +56% | $7.40B | +168% | $8.26 |
| Q4 2025 ended Dec 31, 2025 · from annual report | $19.29B | +43% | $6.64B | +51% | — |
| Q3 2025 ended Sep 30, 2025 | $17.60B | +54% | $5.58B | +475% | $6.21 |
| Q2 2025 ended Jun 30, 2025 | $15.56B | — | $5.66B | — | $6.29 |
| Q1 2025 ended Mar 31, 2025 | $12.73B | — | $2.76B | — | $3.06 |
| Q4 2024 ended Dec 31, 2024 · from annual report | $13.53B | — | $4.41B | — | — |
| Q3 2024 ended Sep 30, 2024 | $11.44B | — | $970.3M | — | $1.07 |
Earnings releases (Form 8-K, Item 2.02)
- Aug 5, 2026: 8-K filing and press release ↗
- Apr 30, 2026: 8-K filing and press release ↗
- Feb 4, 2026: 8-K filing and press release ↗
- Oct 30, 2025: 8-K filing and press release ↗
- Aug 7, 2025: 8-K filing and press release ↗
- May 1, 2025: 8-K filing and press release ↗
- Feb 6, 2025: 8-K filing and press release ↗
- Jan 14, 2025: 8-K filing and press release ↗
Source: SEC EDGAR XBRL company facts (10-Q and 10-K) and 8-K filings. Quarters marked "from annual report" are the annual total minus the three reported quarters, because Eli Lilly reports its fourth quarter only inside the annual report; EPS is not derived for those quarters. Figures are as reported under US GAAP. Not investment advice.